TY - JOUR AB - Paraneoplastic syndromes are immune disorders associated with clinical signs and symptoms caused by substances produced by malignant diseases and are not directly associated with a primary or metastatic tumour. The symptoms are the effects of hormones, immune cross‑reactivity or cytokines. Paraneoplastic nephrotic syndrome (PNS) is often associated with membranous nephropathy (MN) in elderly patients with solid tumours, and there is continued debate regarding whether corticosteroids or immunosuppressants should be combined with cancer therapy for the syndrome. The present report describes a male patient with lung cancer associated with secondary MN who achieved remission under radiotherapy, with no use of corticosteroids or immunosuppressants. This case is rare. Therefore, when treating PNS related to lung cancer, more attention should be paid to the treatment of the cancer. AD - Department of Nephrology, The First Naval Hospital of Southern Theater of People's Liberation Army, Zhanjiang, Guangdong 524005, P.R. China Department of Oncology, The First Naval Hospital of Southern Theater of People's Liberation Army, Zhanjiang, Guangdong 524005, P.R. China Department of Oncology and Southwest Cancer Center, Southwest Hospital, Military Medical University, Shapingba, Chongqing 400038, P.R. China AU - Yu,Xuesong AU - Fan,Zhiming AU - Chen,Wei AU - Wang,Zhe DA - 2020/12/01 DO - 10.3892/mco.2020.2156 IS - 6 JO - Mol Clin Oncol KW - membranous nephropathy nephrotic syndrome paraneoplastic nephrotic syndrome non‑small cell lung cancer PY - 2020 SN - 2049-9450 2049-9469 SP - 86 ST - Lung cancer with nephrotic syndrome as a paraneoplastic syndrome: A case report T2 - Molecular and Clinical Oncology TI - Lung cancer with nephrotic syndrome as a paraneoplastic syndrome: A case report UR - https://doi.org/10.3892/mco.2020.2156 VL - 13 ER -